Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapy
Abstract Tumor genomic profiling is often limited to one or two timepoints due to the invasiveness of tissue biopsies, but longitudinal profiling may provide deeper clinical insights. Using ctDNA data from IMpower150 study, we examined genetic changes in metastatic non-squamous NSCLC post-first-line...
Saved in:
| Main Authors: | Haolun Ding, Min Yuan, Yaning Yang, Xu Steven Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-01-01
|
| Series: | npj Precision Oncology |
| Online Access: | https://doi.org/10.1038/s41698-024-00797-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report
by: Vincent D. de Jager, MD, et al.
Published: (2024-12-01) -
Gut microbial predictors of first-line immunotherapy efficacy in advanced NSCLC patients
by: Anna Grenda, et al.
Published: (2025-02-01) -
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC
by: Maliazurina B. Saad, et al.
Published: (2025-07-01) -
Pembrolizumab and Pemetrexed for Older Patients With Nonsquamous NSCLC and Programmed Cell Death-Ligand 1 Tumor Proportion Scores of Less Than 50%
by: Yoshihito Kogure, MD, PhD, et al.
Published: (2025-03-01) -
Radiomic Analysis and Liquid Biopsy in Preoperative CT of NSCLC: An Explorative Experience
by: Maria Paola Belfiore, et al.
Published: (2025-07-01)